Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour
暂无分享,去创建一个
[1] M Gallorini,et al. Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes , 2001, Journal of neurochemistry.
[2] P. Riederer,et al. Structural Characteristics of Human Substantia Nigra Neuromelanin and Synthetic Dopamine Melanins , 2000, Journal of neurochemistry.
[3] L. Greene,et al. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] S. Ito,et al. Interaction of Human Substantia Nigra Neuromelanin with Lipids and Peptides , 2000, Journal of neurochemistry.
[5] Y. Agid,et al. Preservation of midbrain catecholaminergic neurons in very old human subjects. , 2000, Brain : a journal of neurology.
[6] J. Langston,et al. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure , 1999, Annals of neurology.
[7] M. G. Bridelli,et al. The structure of neuromelanin and its iron binding site studied by infrared spectroscopy , 1999, FEBS letters.
[8] L. Pannell,et al. Enzyme Activity of Macrophage Migration Inhibitory Factor toward Oxidized Catecholamines* , 1999, The Journal of Biological Chemistry.
[9] L. Zecca,et al. X-ray absorption fine-structure spectroscopy studies of Fe sites in natural human neuromelanin and synthetic analogues. , 1998, Biophysical journal.
[10] S. Ito,et al. Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra? , 1998, Neuroscience Letters.
[11] U. Muthane,et al. Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India , 1998, Annals of neurology.
[12] F Beermann,et al. New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain. , 1998, Brain research. Molecular brain research.
[13] A H Stokes,et al. Tyrosinase mRNA is expressed in human substantia nigra. , 1997, Brain research. Molecular brain research.
[14] T. Flatmark,et al. Generation of Reactive Oxygen Species by Tyrosine Hydroxylase: A Possible Contribution to the Degeneration of Dopaminergic Neurons? , 1997, Journal of neurochemistry.
[15] Okun Mr. The role of peroxidase in neuromelanin synthesis: a review. , 1997 .
[16] T. Shima,et al. Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study. , 1997, Free radical biology & medicine.
[17] M. Okun. The role of peroxidase in neuromelanin synthesis: a review. , 1997, Physiological chemistry and physics and medical NMR.
[18] H. M. Swartz,et al. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain , 1996, Neuroscience.
[19] John Smythies,et al. On the function of neuromelanin , 1996, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[20] M. Barcikowska,et al. Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study , 1996, Movement disorders : official journal of the Movement Disorder Society.
[21] P. Riederer,et al. Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra , 1995, Journal of neurochemistry.
[22] T. Sarna,et al. The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems. , 1995, Biochimica et biophysica acta.
[23] R. Strong,et al. Prostaglandin H Synthetase‐Mediated Metabolism of Dopamine: Implication for Parkinson's Disease , 1995, Journal of neurochemistry.
[24] J N Rodríguez-López,et al. Tyrosinase: a comprehensive review of its mechanism. , 1995, Biochimica et biophysica acta.
[25] T. Hastings. Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase , 1995, Journal of neurochemistry.
[26] J Cheng,et al. X-ray characterization of melanins--I. , 1994, Pigment cell research.
[27] E. Rosengren,et al. Neuromelanin of the Human Substantia Nigra: A Mixed‐Type Melanin , 1994, Journal of neurochemistry.
[28] D. Radice,et al. Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain , 1994, Journal of neurochemistry.
[29] B. Bergamasco,et al. Evidence for a Glycidic‐Lipidic Matrix in Human Neuromelanin, Potentially Responsible for the Enhanced Iron Sequestering Ability of Substantia Nigra , 1994, Journal of neurochemistry.
[30] J Cheng,et al. X-ray characterization of melanins--II. , 1994, Pigment cell research.
[31] H. M. Swartz,et al. The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: A hypothesis , 1994, Journal of neural transmission. Parkinson's disease and dementia section.
[32] W. S. Enochs,et al. Purified Human Neuromelanin, Synthetic Dopamine Melanin as a Potential Model Pigment, and the Normal Human Substantia Nigra: Characterization by Electron Paramagnetic Resonance Spectroscopy , 1993, Journal of neurochemistry.
[33] H. M. Swartz,et al. Total and paramagnetic metals in human substantia nigra and its neuromelanin , 1993, Journal of neural transmission. Parkinson's disease and dementia section.
[34] C. W. Olanow,et al. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.
[35] Y. Agid,et al. Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content? , 1992, Journal of neurochemistry.
[36] K. Jellinger,et al. Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.
[37] W. Gibb,et al. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease , 1992, Brain Research.
[38] E. Parati,et al. The chemical characterization of melanin contained in substantia nigra of human brain. , 1992, Biochimica et biophysica acta.
[39] T. Sarna,et al. Modulation by neuromelanin of the availability and reactivity of metal ions , 1992, Annals of neurology.
[40] K. Wakamatsu,et al. Cysteinyldopamine is not incorporated into neuromelanin , 1991, Neuroscience Letters.
[41] J. Adams,et al. Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Could oxidative stress be involved in the brain? , 1991, Biochemical pharmacology.
[42] P Riederer,et al. Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.
[43] H J Gundersen,et al. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[44] Max B. Streifler,et al. Parkinson's disease : anatomy, pathology and therapy , 1990 .
[45] C. Marsden,et al. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.
[46] N. Lindquist,et al. Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin , 1988, Neuroscience Letters.
[47] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[48] B. Cozzi,et al. Neuromelanin in the substantia nigra of adult horses. , 1988, Anatomischer Anzeiger.
[49] R. Ramsay,et al. Biochemical Events in the Development of Parkinsonism Induced by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine , 1987, Journal of neurochemistry.
[50] S J Kish,et al. Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.
[51] R. Fariello,et al. Neuromelanic pigment in substantia nigra neurons of rats and dogs , 1986, Neuroscience Letters.
[52] J W Langston,et al. MPTP: current concepts and controversies. , 1986, Clinical neuropharmacology.
[53] D. Cowen. The Melanoneurons of the Human Cerebellum (Nucleus Pigmentosus Cerebellaris) and Homologues in the Monkey , 1986, Journal of neuropathology and experimental neurology.
[54] A. Carlsson,et al. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species , 1986, Neuropharmacology.
[55] S. Snyder,et al. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. , 1986, Science.
[56] W. D. Ehmann,et al. Brain trace element concentrations in aging , 1984, Neurobiology of Aging.
[57] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[58] David M. A. Mann,et al. Possible role of neuromelanin in the pathogenesis of Parkinson's disease , 1983, Mechanisms of Ageing and Development.
[59] B. Bogerts. A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker , 1981, The Journal of comparative neurology.
[60] D. Graham. On the origin and significance of neuromelanin. , 1979, Archives of pathology & laboratory medicine.
[61] T. Sokoloski,et al. Binding of dopaminergic drugs by the neuromelanin of the substantia nigra, synthetic melanins and melanin granules. , 1978, Federation proceedings.
[62] P. Mcgeer,et al. Aging and extrapyramidal function. , 1977, Archives of neurology.
[63] L. Feinendegen,et al. Trace element concentration in human brain. Activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium. , 1975, Brain : a journal of neurology.
[64] Van Woert Mh,et al. Biochemistry of neuromelanin. , 1974 .
[65] M. V. Van Woert,et al. Biochemistry of neuromelanin. , 1974, Advances in neurology.
[66] P. Yates,et al. Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. , 1974, Brain : a journal of neurology.
[67] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[68] H. Barden. THE HISTOCHEMICAL RELATIONSHIP OF NEUROMELANIN AND LIPOFUSCIN , 1969, Journal of neuropathology and experimental neurology.
[69] G. Fenichel,et al. Studies on neuromelanin: II. Melanin in the brainstems of infants and children , 1968, Neurology.
[70] G. Fenichel,et al. Studies on neuromelanin , 1967, Neurology.
[71] H. Moses,et al. Light and electron microscopic studies of pigment in human and rhesus monkey substantia nigra and locus coeruleus , 1966, The Anatomical record.
[72] V. Tennyson,et al. Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's Disease , 1965 .
[73] Marsden Cd. Pigmentation in the nucleus substantiae nigrae of mammals. , 1961 .
[74] C. Marsden. Pigmentation in the nucleus substantiae nigrae of mammals. , 1961, Journal of anatomy.
[75] J. Foley,et al. ON THE NATURE OF PIGMENT GRANULES IN THE CELLS OF THE LOCUS COERULEUS AND SUBSTANTIA NIGRA , 1958, Journal of neuropathology and experimental neurology.
[76] A. Adler. Melanin pigment in the brain of the gorilla , 1942 .
[77] H. Scherer. Melanin pigmentation of the substantia nigra in primates , 1939 .
[78] A. Adler. Melanin pigment in the central nervous system of vertebrates , 1939 .